Prudential PLC Biogen Inc. Transaction History

Prudential PLC

$14.3 Billion
Q2 2024

A detailed history of Prudential PLC transactions in Biogen Inc. stock. As of the latest transaction made, Prudential PLC holds 2,508 shares of BIIB stock, worth $435,865. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,508

Previous 12,952 80.64%

Holding current value

$435,865

Previous $2.79 Million 79.19%

% of portfolio

0.0%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $1.99 Million - $2.47 Million	-10,444 Reduced 80.64%	2,508 $581,000
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $1.25 Million - $1.58 Million	5,910 Added 83.93%	12,952 $2.79 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $1.72 Million - $2.07 Million	-7,741 Reduced 52.36%	7,042 $1.82 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $33,435 - $37,737	-132 Reduced 0.89%	14,783 $3.8 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $1.87 Million - $2.16 Million	6,776 Added 83.25%	14,915 $4.25 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $5,644 - $6,431	22 Added 0.27%	8,139 $2.26 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $1.12 Million - $1.37 Million	4,453 Added 121.53%	8,117 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $79,628 - $109,800	409 Added 12.57%	3,664 $978,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $21,004 - $24,978	-112 Reduced 3.33%	3,255 $664,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $71,501 - $90,087	-369 Reduced 9.88%	3,367 $709,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $836,565 - $1.08 Million	3,736 New	3,736 $896,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $3.15 Million - $3.69 Million	-12,963 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $144,591 - $217,645	-612 Reduced 4.51%	12,963 $3.17 Million
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $3.59 Million - $4.15 Million	13,575 New	13,575 $3.85 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $39.3 Million - $54.3 Million	-178,663 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $2.3 Million - $2.58 Million	10,572 Added 6.29%	178,663 $41.6 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $5.4 Million - $5.96 Million	24,640 Added 17.18%	168,091 $39.3 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $5.09 Million - $7.96 Million	23,478 Added 19.57%	143,451 $33.9 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $247,029 - $312,889	-887 Reduced 0.73%	119,973 $36.1 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $271,203 - $354,658	-924 Reduced 0.76%	120,860 $42.7 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $879,688 - $1.05 Million	3,416 Added 2.89%	121,784 $35.3 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.56 Million - $3.61 Million	-9,824 Reduced 7.66%	118,368 $32.4 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $2.68 Million - $3 Million	8,700 Added 7.28%	128,192 $40.8 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $2.18 Million - $2.55 Million	7,749 Added 6.93%	119,492 $37.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	111,743	111,743 $30.3 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account